Royal Bank of Canada’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$571K Sell
8,899
-12,137
-58% -$1.11M ﹤0.01% 4039
2025
Q4
$2.74M Sell
21,036
-3,360
-14% -$461K ﹤0.01% 2897
2025
Q3
$2.63M Sell
24,396
-4,794
-16% -$522K ﹤0.01% 3178
2025
Q2
$2.69M Sell
29,190
-289
-1% -$22.7K ﹤0.01% 3060
2025
Q1
$2.61M Buy
29,479
+6,840
+30% +$593K ﹤0.01% 2756
2024
Q4
$1.74M Buy
22,639
+10,305
+84% +$720K ﹤0.01% 3116
2024
Q3
$524K Buy
12,334
+11,190
+978% +$378K ﹤0.01% 4069
2024
Q2
$30K Buy
1,144
+183
+19% +$3.47K ﹤0.01% 5897
2024
Q1
$9K Buy
961
+676
+237% +$4.06K ﹤0.01% 6256
2023
Q4
$1K Sell
285
-1,030
-78% -$2.4K ﹤0.01% 6998
2023
Q3
$5K Buy
1,315
+1,011
+333% +$5.54K ﹤0.01% 6626
2023
Q2
$2K Sell
304
-501
-62% -$3.97K ﹤0.01% 6912
2023
Q1
$10K Buy
805
+176
+28% +$2.35K ﹤0.01% 6338
2022
Q4
$6K Buy
629
+534
+562% +$11.8K ﹤0.01% 6703
2022
Q3
$3K Buy
95
+32
+51% +$1.47K ﹤0.01% 6933
2022
Q2
$3K Buy
63
+27
+75% +$1.83K ﹤0.01% 6866
2022
Q1
$4K Sell
36
-161
-82% -$17.9K ﹤0.01% 7341
2021
Q4
$29K Buy
197
+55
+39% +$12.3K ﹤0.01% 6637
2021
Q3
$36K Sell
142
-295
-68% -$101K ﹤0.01% 6352
2021
Q2
$202K Buy
437
+347
+386% +$149K ﹤0.01% 5063
2021
Q1
$45K Buy
+90
New +$46.8K ﹤0.01% 5959

Other funds holding WGS

Royal Bank of Canada's WGS Position: Q1 2026 in Review

Royal Bank of Canada reduced its GeneDx Holdings (WGS) stake by 58% in Q1 2026, selling an estimated $1.11M and leaving 8,899 shares worth $571K. The position accounts for ﹤0.01% of the portfolio, ranked #4039.

Royal Bank of Canada first reported a position in WGS in Q1 2021 and has held it in 21 quarters since. The position peaked at $2.74M in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • Royal Bank of Canada held 8,899 shares of GeneDx Holdings worth $571K as of Q1 2026.
  • Royal Bank of Canada sold 12,137 GeneDx Holdings shares in Q1 2026, an estimated $1.11M.
  • GeneDx Holdings made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #4039 holding.
  • Royal Bank of Canada first reported a position in GeneDx Holdings in Q1 2021 and has held it in 21 quarters since.
  • Royal Bank of Canada's GeneDx Holdings position peaked at $2.74M in Q4 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.